Ketamine News and Research

RSS
mTOR protein: A key mediator of antidepressant effects of ketamine

mTOR protein: A key mediator of antidepressant effects of ketamine

Brain & Behavior Research Foundation announces recipients of NARSAD Investigator Grants

Brain & Behavior Research Foundation announces recipients of NARSAD Investigator Grants

Serotonin 2C receptors induce fast-acting antidepressant effects in mice

Serotonin 2C receptors induce fast-acting antidepressant effects in mice

Neuropsychoanalysis Association to host conference on depression

Neuropsychoanalysis Association to host conference on depression

Blood test can help predict which bipolar patients will benefit from Ketamine

Blood test can help predict which bipolar patients will benefit from Ketamine

Pregabalin drug can help reduce incidence of chronic pain following cardiac surgery

Pregabalin drug can help reduce incidence of chronic pain following cardiac surgery

Researchers develop model that completes bridge between cellular and human studies of schizophrenia

Researchers develop model that completes bridge between cellular and human studies of schizophrenia

Ketamine anesthesia drug can cause learning and memory disorders in children

Ketamine anesthesia drug can cause learning and memory disorders in children

UTHealth psychiatrists win 2013 American Psychiatric Association's Mind Games competition for the third time

UTHealth psychiatrists win 2013 American Psychiatric Association's Mind Games competition for the third time

PTSD patients with Met-66 allele of BDNF show poorer response to exposure therapy

PTSD patients with Met-66 allele of BDNF show poorer response to exposure therapy

Low-dose ketamine anesthetic has potential to alleviate severe depression

Low-dose ketamine anesthetic has potential to alleviate severe depression

Naurex initiates Phase I trial of NRX-1074 in normal volunteers

Naurex initiates Phase I trial of NRX-1074 in normal volunteers

GLYX-13 drug induces antidepressant results without street drug side effects

GLYX-13 drug induces antidepressant results without street drug side effects

Study sheds light on the phenomenon of general anesthesia

Study sheds light on the phenomenon of general anesthesia

Patients with treatment-resistant depression benefit from ketamine

Patients with treatment-resistant depression benefit from ketamine

Neuroperspective reviews status and prospects of therapeutics for Parkinson's disease

Neuroperspective reviews status and prospects of therapeutics for Parkinson's disease

Researchers study how ketamine reduces side effects of ECT in people with severe depression

Researchers study how ketamine reduces side effects of ECT in people with severe depression

Cerecor obtains exclusive, worldwide rights to NR2B receptor antagonist from Merck

Cerecor obtains exclusive, worldwide rights to NR2B receptor antagonist from Merck

Ketamine may help treat severe depression, reduce suicidal urges, UAB researchers say

Ketamine may help treat severe depression, reduce suicidal urges, UAB researchers say

New hunt for intrinsic mechanism linked to schizophrenia

New hunt for intrinsic mechanism linked to schizophrenia

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.